Roivant Sciences Ltd.

25
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG762791017
USD
21.18
1.08 (5.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Roivant Sciences Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-681.00
4,567.00
-1,224.00
-923.00
-898.00
-560.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-77.00
19.00
6.00
15.00
71.00
15.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-839.00
-765.00
-843.00
-677.00
-552.00
-761.00
Cash Flow from Investing Activities
-1,766.00
5,203.00
-44.00
303.00
-31.00
1,694.00
Cash Flow from Financing Activities
-1,219.00
419.00
499.00
306.00
456.00
217.00
Net Cash Inflow / Outflow
-3,824.00
4,858.00
-381.00
-67.00
-127.00
1,150.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
6.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Roivant Sciences Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-681.59
-27.035
-654.00
-2421.14%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-77.046
60.921
-137.00
-226.47%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-839.451
175.394
-1,014.00
-578.61%
Cash Flow from Investing Activities
-1766.291
-86.383
-1,680.00
-1944.72%
Cash Flow from Financing Activities
-1219.794
-82.902
-1,137.00
-1371.37%
Net Cash Inflow / Outflow
-3824.789
6.032
-3,830.00
-63508.31%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.747
-0.077
0.00
1070.13%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is -9.69% vs 9.26% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-839.45
-765.27
-9.69%